Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Journal of Personalized Medicine
|
October 29, 2020
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI
Hossein Taghizadeh, Matthias Unseld, Martina Spalt, et al.
ESMO Open
|
September 4, 2020
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
Thorsten Fuereder, Anna Sophie Berghoff, Gerwin Heller, et al.
ESMO Open
|
August 20, 2019
Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI
Markus Kieler, Matthias Unseld, Daniela Bianconi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2022
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study
Maximilian J Mair, Julia M Berger, Manfred Mitterer, et al.
JAMA Oncology
|
September 30, 2021
Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations
Maximilian J Mair, Julia M Berger, Anna S Berghoff, et al.
Journal of Psychosomatic Research
|
December 17, 2024
The myth of a cancer-specific temperament: An analysis of affective temperament in cancer patients
Elisabeth L Zeilinger, Matthias Knefel, Andreas Erfurth, et al.
JACC. Cardiooncology
|
January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors
Florian Moik, Jakob M Riedl, Dominik Barth, et al.
Oncotarget
|
March 9, 2019
Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology
Gerald W Prager, Matthias Unseld, Fredrik Waneck, et al.
European Journal of Radiology
|
November 22, 2023
Metabolic tumor volume and sites of organ involvement predict outcome in NSCLC immune-checkpoint inhibitor therapy
Daria Kifjak, Maximilian Hochmair, Daniel Sobotka, et al.
Frontiers in Oncology
|
January 19, 2024
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial
Stefano Cavalieri, Eleonora Bruno, Mara Serena Serafini, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Journal of Personalized Medicine
|
October 29, 2020
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI
Hossein Taghizadeh, Matthias Unseld, Martina Spalt, et al.
ESMO Open
|
September 4, 2020
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
Thorsten Fuereder, Anna Sophie Berghoff, Gerwin Heller, et al.
ESMO Open
|
August 20, 2019
Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI
Markus Kieler, Matthias Unseld, Daniela Bianconi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2022
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study
Maximilian J Mair, Julia M Berger, Manfred Mitterer, et al.
JAMA Oncology
|
September 30, 2021
Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations
Maximilian J Mair, Julia M Berger, Anna S Berghoff, et al.
Journal of Psychosomatic Research
|
December 17, 2024
The myth of a cancer-specific temperament: An analysis of affective temperament in cancer patients
Elisabeth L Zeilinger, Matthias Knefel, Andreas Erfurth, et al.
JACC. Cardiooncology
|
January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors
Florian Moik, Jakob M Riedl, Dominik Barth, et al.
Oncotarget
|
March 9, 2019
Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology
Gerald W Prager, Matthias Unseld, Fredrik Waneck, et al.
European Journal of Radiology
|
November 22, 2023
Metabolic tumor volume and sites of organ involvement predict outcome in NSCLC immune-checkpoint inhibitor therapy
Daria Kifjak, Maximilian Hochmair, Daniel Sobotka, et al.
Frontiers in Oncology
|
January 19, 2024
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial
Stefano Cavalieri, Eleonora Bruno, Mara Serena Serafini, et al.
Page
of 8